Bharatpur Eye Hospital
Bharatpur, Chitwan, Nepal
NCT Number: NCT03278587
The vast majority of blindness is avoidable. The World Health Organization (WHO) estimates that 80% of cases of visual impairment could be prevented or reversed with early diagnosis and treatment. The leading causes of visual impairment are cataract and refractive error, followed by glaucoma, age-related macular degeneration (AMD), and diabetic retinopathy (DR). Loss of vision from these conditions is not inevitable; however, identifying at-risk cases and linking cases with appropriate care remain significant challenges.
Eye health care systems must determine optimal strategies for reaching people outside of their immediate orbit in order to reduce visual impairment. Visual impairment can be reduced by case detection of prevalent disease like cataract and refractive error, or by screening for early disease like glaucoma, AMD, and DR and preventing progression. Systems around the world have developed numerous approaches to both case detection and screening but there is very little research to support the choice of allocating resources to case detection or screening and little data exists on the cost effectiveness of the various approaches to each.
VIEW II Pilot is a cluster-randomized trial to determine the effectiveness of different approaches to community-based case detection and screening for ocular disease. Communities will be randomized to one of four arms: 1) a comprehensive ocular screening program, 2) a cataract camp-based program, 3) a community health worker-based program, and 4) no program.
Looking for future studies?
Notify Me50 year and older
All sexes
Interventional
Not applicable
Bharatpur, Chitwan, Nepal
Specific Aim 1: to determine whether screening leads to increased visual acuity compared to the cataract camp approach.
Specific Aim 2: to determine whether a community health volunteer program increases the rate of cataract surgery compared to a no program.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
(community-level):
Inclusion criteria
(individual-level):
In communities randomized to receive the screening program, all adults aged 50 and older will be eligible to receive screening for ocular disease. Screening assessments include visual acuity, refraction, intra-ocular pressure, fundus photography, and anterior segment photography. Participants meeting criteria for referral based on screening assessments will be referred to the nearest eye care center or eye hospital for further evaluation.
In communities randomized to receive the cataract camp program, all adults aged 50 and older will be eligible to participate in a routine cataract camp run by Bharatpur Eye Hospital. Trained ophthalmic personnel and assistants will perform case detection for cataract via visual acuity, pen light exam, and indirect ophthalmoscope exam per Bharatpur Eye Hospital's standard cataract camp program. Participants with cataracts will be referred to the nearest eye care center or eye hospital for further evaluation.
In communities randomized to receive the community health worker program, all adults aged 50 and older will be eligible to participate. Existing community health workers will be trained to perform case detection for cataract via visual acuity assessment. Participants with cataracts will be referred to the nearest eye care center or eye hospital for further evaluation.
Time frame: 1 year
Primary outcome for specific aim 1, comparison between screening and case detection arms
Time frame: 1 year
Primary outcome for specific aim 2, comparison between community health worker program and no program arms
Time frame: 1 year
Cost-effectiveness of all 4 arms will be assessed
Time frame: 1 year
Visual acuity of population 50 years and older in all arms will be compared
Time frame: 1 year
Number of cases of ocular disease in the screening and case detection arms will be compared
University of California, San Francisco
Other
Acronym: VIEW II Pilot
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT04328207
Behavior, Behavior, Health
Birmingham, Alabama, United States
View Trial DetailsNCT02390245
Arterial Occlusive Diseases, Branch Retinal Arterial Occlusion
Philadelphia, Pennsylvania, United States
View Trial DetailsNCT07015034
Age-Related Macular Degeneration, Blindness
Copenhagen, Capital Region, Denmark
View Trial DetailsNCT07135570
AMD - Age-Related Macular Degeneration, Cardiovascular Diseases
Char Fasson, Bhola, Bangladesh
View Trial Details